This week we highlight patent infringement claims, ongoing manufacturing expansion, underrepresentation of pregnant women in clinical data, and the National Institutes of Health’s All of Us genomic study. Each week we highlight five things you need to know about in ...

Each week we highlight five things affecting the life sciences industry. Here’s the latest. BioCentury reports that the biopharma industry is actively lobbying for changes to the Biosecure Act aiming to modify legislative measures that could impact U.S. companies’ ties ...

Each week we highlight five things affecting the life sciences industry. Here’s the latest. On April 29, the U.S. Food and Drug Administration issued a final rule regarding regulation of laboratory developed tests, following a proposed rule in the fall ...

Despite recent headlines highlighting cybersecurity challenges and the departure of major retailers from specific health care segments, the industry continues to demonstrate robust jobs growth. Health care jobs gains remain strong, according to the U.S. monthly report on April numbers, ...

This week we highlight continued investment in virtual trials, robotic injections, costs of COVID-19 treatments and the need to understand drug safety for pregnant patients. Finally, we look at the most recent round of drug pricing reform in Congress which ...

This week we highlight a Food and Drug Administration approval for an alternative to LASIK, promising results for a less invasive brain interface device and a precision biotech who has recently raised an additional $100 million in funding. Finally, we ...

Each week we highlight five things affecting the life sciences industry. Here’s the latest. According to data from Evaluate, the orphan drug market is projected to expand to $270 billion by 2028. This sector, while experiencing a deceleration in growth ...

This week we highlight a slow start to the year for life sciences initial public offerings, Medicare’s decision on Alzheimer’s disease reimbursement, the use of machine learning and artificial intelligence in clinical trials and the rapidly growing market for virtual ...

Each week we highlight five things affecting the life sciences industry. Here’s the latest. According to Reuters, the European Union is set to begin an investigation into China’s medical device procurement practices, concerned that Beijing is unfairly favoring domestic manufacturers. ...

This week we highlight new guidance from the U.S. Food and Drug Administration on ensuring that clinical trials are inclusive, Biogen’s challenges with marketing its new Alzheimer’s drug, a COVID-19 breathalyzer and how a new type of T cell could ...